Mohammad Shenasa

Characteristics of local electrogram predicting successful transcatheter radiofrequency ablation of left-sided accessory pathways

OBJECTIVES The purpose of this study was to analyze and compare the local electrograms recorded at successful and unsuccessful sites of ablation to identify the criteria that may predict successful sites and minimize unnecessary radiofrequency delivery. BACKGROUND Transcatheter ablation of accessory pathways using radiofrequency energy requires extremely precise localization of an accessory pathway. METHODS Local electrograms from 50 consecutive patients with left-sided accessory pathways who underwent transcatheter radiofrequency ablation were analyzed. During catheter ablation, localization of accessory pathways was performed in 39 pathways during pre-excited sinus rhythm and in 14 pathways during orthodromic tachycardia. A total of 429 local electrograms at target sites obtained before delivery of radiofrequency current was analyzed. A prospective study was performed in another 20 patients using the criteria derived from the retrospective study. RESULTS Accessory pathway conduction block was achieved in 36 (92%) of 39 pathways in which mapping was performed during pre-excited sinus rhythm and in 9 (64%) of 14 pathways in which mapping was performed during orthodromic tachycardia (p less than 0.05). When mapping was performed during pre-excited sinus rhythm, a combination of four variables (that is, an accessory pathway potential, stability of local electrograms, atrial activation greater than 1 mV and ventricular activation preceding the onset of the delta wave) showed a 62% probability of success. In contrast, excluding these variables resulted in a 95% probability of failure (noneffective or transiently effective). The prospective study shows that the use of these criteria can significantly reduce the number of current applications. When mapping was performed during orthodromic tachycardia, recording the earliest atrial activation was the most powerful predictor of success. A stable local electrogram with a small notch on the ventricular potential, presumed to be an accessory pathway potential, may add predictive value. CONCLUSIONS Transcatheter radiofrequency ablation is highly effective in the treatment of patients with left-sided accessory pathways. Specific characteristics of local electrograms can be important predictors of success or failure. Mapping during pre-excited rhythm renders ablation more effective than does mapping during orthodromic tachycardia.

Radiofrequency Catheter Ablation of Ventricular Tachycardia Following Implantation of an Automatic Cardioverter Defibrillator

The present study reports on the complementary role of two nonpharmacological options of antiarrhythmic therapy. Background: Catheter ablation, antitachycardia surgery, and the implanfahie cardioverter de/ibrillator (ICD)have become important tools in the management of ventricuiar tachyarrhythmias. However, the emergence of ventricuiar tachyarrhythmias after implantation of an ICD is possihie because the arrhythmogenic suhstrate is not affected. Patients and Methods:Six of 180 patients developed frequent episodes of monomorphic ventricular tachycardia (n = 2) or incessant ventricular tachycardia (n = 4) following implantation of an ICD and underwent radio/requency (RF)catheter ablation. Catheter ablation was performed using a HF generator HAT 200. Energy was delivered between a 4‐mm tip electrode of the ahiation catheter and a patch electrode. Results: Catheter ablation was done 6.8 ± 5 months following ICD implantation; 6 ± 2.2 RF impulses were delivered at the site of origin of ventricuiar tachycardia chararcterized by early endocardial activation during ventricular tachycardia, identical pace mapping and long latency between stimulus, and QRS‐complex in five patients. New bundle branch reentry was the underlying mechanism of ventricular tachycardia in one patient. RF catheter ablation resulted in termination o/ incessant ventricular tachycardia. Immediately postabiation, the documented ventricular tachycardia was rendered noninducible in all patients. No ICD malfunctions have been observed. One patient died due to heart failure 24 hours after successful ablation of the incessant ventricular tachycardia. During a follow‐up of 5–19 months, episodes of ventricular tachycardia recurred in four patients. All episodes could be controlled by the ICD without frequent cardioversions. Conclusion: RF catheter ablation is o complementary therapeutic option in case of frequent or incessant ventricular tachycardia after ICD implantation.

Patients With Valvular Heart Disease Presenting With Sustained Ventricular Tachyarrhythmias or Syncope Results of Programmed Ventricular Stimulation and Long-term Follow-up

BACKGROUND Programmed ventricular stimulation is commonly used to guide therapy in post-myocardial infarction patients with sustained monomorphic ventricular tachycardia (VT) or ventricular fibrillation (VF). In patients with valvular heart disease presenting with spontaneous VT, VF, or syncope, the usefulness of this technique is still unclear. The aim of the study was to analyze whether programmed ventricular stimulation was helpful in guiding therapy and determining prognosis in 97 patients with valvular heart disease presenting with VT (60%), VF (18%), or syncope (22%). METHODS AND RESULTS Patients were classified as having either predominant ventricular pressure or volume overload or no significant pressure or volume overload. Overall, sustained VT or VF was inducible in 38 (39%) and 19 (20%) patients, respectively. Forty-six (47%) patients were discharged on antiarrhythmic drugs, 29 (30%) received an implantable cardioverter-defibrillator, and 22 (23%) remained without therapy. With serial drug testing, inducibility was completely or partially suppressed in 18 (19%) and 9 (9%) patients, respectively. During a mean follow-up of 51 months (n=97), 17 patients (18%) died (sudden death, n=7; heart failure, n=4; noncardiac causes, n=6). One-, 2- and 3-year event-free survival for sudden death, sustained VT, or VF was 77%, 68%, and 61%, respectively. Only inducibility of VT during baseline study (P<.0003) and left ventricular volume overload (P<.008) were significant predictors of arrhythmic events. Recurrence of arrhythmic events occurred in 56% and 56% of patients with complete or partial suppression of inducibility during serial drug testing as well as in 10 of 19 (53%) patients without a change in inducibility. CONCLUSIONS Although programmed ventricular stimulation seems to predict adverse outcome, serial drug testing is unreliable in guiding therapy. The type of workload imposed on the ventricles influences outcome, being worse in patients with left ventricular volume overload. Therefore, implantation of a cardioverter-defibrillator should be considered early for the management of these patients.

Recurrence and late block of accessory pathway conduction following radiofrequency catheter ablation.

Recurrence After RF Ablation of AP. Introduction: Many issues regarding the recurrence of accessory pathway conduction and the long‐term outcome of late block of accessory pathway conduction are still unknown or controversial.

Electrophysiologic variables characterizing the induction of ventricular tachycardia versus ventricular fibrillation after myocardial infarction : relation between ventricular late potentials and coupling intervals for the induction of sustained ventricular tachyarrhythmias

OBJECTIVES The aim of this study was to analyze the relations between the presence of ventricular conduction delay and the necessary coupling intervals for the induction of sustained ventricular tachyarrhythmias. METHODS The electrophysiologic and signal-averaged electrocardiographic (ECG) data from 83 patients with previous myocardial infarction and inducible sustained monomorphic ventricular tachycardia (n = 71) and ventricular fibrillation (n = 12) were analyzed. RESULTS The sum of the coupling intervals needed for inducing ventricular tachycardia and ventricular fibrillation was 485 +/- 59 ms and 387 +/- 36 ms, respectively (p < 0.001). The mean difference between the effective refractory period and the second coupling interval for the induction of ventricular tachycardia and ventricular fibrillation was -3 +/- 40 ms and 24 +/- 29 ms, respectively (p < 0.02). QRS duration and duration of terminal low amplitude signals of the QRS complex (p < 0.004) were longer in patients with inducible ventricular tachycardia than in patients with inducible ventricular fibrillation. The root mean square of the voltage during the last 40 ms of QRS complex was lower in patients with inducible ventricular tachycardia than in patients with inducible ventricular fibrillation (p < 0.007). Patients with inducible ventricular tachycardia presented with a greater prevalence of ventricular late potentials than that of patients with inducible ventricular fibrillation (p < 0.007). For arrhythmia induction, significantly shorter coupling intervals were necessary in patients without than in patients with ventricular late potentials. A positive correlation was found between the cycle length of the induced ventricular tachycardia and the filtered QRS duration as well as with the sum of the coupling intervals. CONCLUSIONS Induction of ventricular fibrillation requires shorter coupling intervals than does induction of ventricular tachycardia. The presence of ventricular conduction delay seems to be a marker of facilitated induction of sustained monomorphic ventricular tachycardia rather than of ventricular fibrillation. The coupling intervals required to induce ventricular tachycardia or fibrillation are longer in patients with than in those without an abnormal signal-averaged ECG.

Localization and radiofrequency catheter ablation of left-sided accessory pathways during atrial fibrillation Feasibility and electrogram criteria for identification of appropriate target sites

OBJECTIVES The purpose of the present study was to assess the feasibility of and electrophysiologic criteria for successful radiofrequency catheter ablation of left-sided accessory pathways during atrial fibrillation in patients with Wolff-Parkinson-White syndrome. BACKGROUND The onset of recurrent or sustained atrial fibrillation can complicate or significantly prolong accessory pathway catheter ablation procedures. METHODS We studied 19 consecutive patients (mean age [+/-SD] 44 +/- 16 years) with Wolff-Parkinson-White syndrome who had ongoing atrial fibrillation with rapid anterograde conduction over the accessory pathway (mean ventricular rate [+/-SD] 173 +/- 26 beats/min, range 130 to 220) at the beginning of the localization procedure during radiofrequency catheter ablation. Localization and ablation of the accessory pathway were performed with a 7F deflectable catheter (4-mm tip) that was placed underneath the mitral valve annulus. The electrophysiologic criteria from unipolar and bipolar local electrograms were compared for successful (n = 18) and unsuccessful (n = 39) sites. RESULTS The accessory pathways were localized in the left posteroseptal (n = 6), posterior (n = 1), posterolateral (n = 7) and lateral (n = 5) regions and successfully ablated during atrial fibrillation in 18 (95%) of 19 patients with a mean of 3 +/- 2 radiofrequency pulses (range 1 to 8, median 2). Presence of an accessory pathway potential (94% vs. 44%), early activation time of the ventricular electrogram (-3.2 +/- 9.2 vs. -15.3 +/- 12.6 ms) and recording of atrial activation (88% vs. 61%) from the ablation catheter were helpful in identifying successful sites (p < 0.001, p < 0.001 and p < 0.05, respectively, compared with unsuccessful sites). In addition, the ventricular activation time in relation to the intrinsic deflection of the unipolar electrogram was significantly earlier at successful than unsuccessful sites (18.1 +/- 4.8 vs. 24.4 +/- 6.6 ms, p < 0.01). A QS complex on the unipolar electrogram was observed at 96% of successful sites and at 94% of unsuccessful sites (p = 0.74). Multivariate logistic regression analysis revealed that the presence of an accessory pathway potential (p < 0.002) and early ventricular activation time in relation to the onset of the QRS complex (p < 0.001) were independent predictors of ablation success. CONCLUSIONS Localization and radiofrequency catheter ablation of left-sided accessory pathways is possible in patients with sustained atrial fibrillation and rapid anterograde conduction over the accessory pathway during the ablation procedure. The electrophysiologic criteria described here can be used to reliably identify successful sites for radiofrequency ablation.

Radiofrequency Ablation of Accessory Pathways: Characteristics of Transiently and Permanently Effective Pulses

The purpose of this study was to characterize and compare the radiofrequency current applications that produced permanent or transient accessory pathway conduction block. One hundred fifty‐two radiofrequency energy applications that induced permanent (permanently effective pulses, n = 48J or transient (transiently effective pulses, n = 104) accessory pathway block in 57 patients with 60 accessory pathways were analyzed. The time from the onset of current application to disappearance of preexcitation or termination of supraventricular tachycardia by permanently effective pulses was 1‐15 seconds (mean 3.6 ± 3.8 sec) compared to 2‐29 seconds (mean 11.5 ± 7.5 sec) by transiently effective pulses (P < 0.01). After transiently effective pulses that induced block in accessory pathway, conduction resumed within 5 minutes while induced block by permanently effective pulses persisted in 44 of 48 patients (92%) during follow‐up of 11 ± 12 months. The accessory pathway conduction returned in the remaining four patients after ablation 2 weeks to 7 months. After transiently effective pulses, 41 impulses were delivered to the same site using a higher power output (n = 32) and/or longer energy delivery duration (n = 20) without new mapping of accessory pathway location. Thirty‐six of these impulses again resulted in transient accessory pathway block, four had no effect, only one impulse induced a permanent block in the accessory pathway. Pulses with higher power outputs tended to induce transient effects more frequently than pulses with lower energy. Thus, if block in the accessory pathway during radiofrequency ablation occurs within 5 seconds of current application, and if the accessory pathway block persists over 5 minutes, permanent block of accessory pathway conduction may be expected. If 15 seconds after onset of ablation still no effect is noted, it is unlikely that any permanent effect will occur at longer pulse duration. Therefore, it is not useful to repeat energy delivery after a transiently effective pulse with higher power settings and/or longer pulse duration to the same site without new mapping for localization of the accessory pathway. Further experimental studies are needed to explain the mechanisms of transient effects of radiofrequency pulses.

Role of Ventricular Tachycardia Surgery and Catheter Ablation As Complements or Alternatives To the Implantable Cardioverter Defibrillator in the 1990s

Although the implantable cardioverter defibrillator is used increasingly, other nonpharmacological approaches have their indications and merits. Furthermore, as the natural history of ventricular tachyarrhythmias or their underlying structural cardiac abnormality, i.e., coronary artery disease, dilated cardiomyopathy, arrhythmogenic right ventricular disease, etc. change, the mode of therapy may be modified accordingly. Because of the disappointing results of the CAST study in previously asymptomatic patients after myocardial infarction and the evidence that failure of one or two antiarrhythmic drugs tested by programmed ventricular stimulation in patients with documented sustained ventricular tachycardia or fibrillation predicts further drug failure, there will be a significant increase in the use of implantable cardioverters defibrillators in the 1990s. However, care should be taken to avoid inappropriate use of these devices.

Subthreshold electrical stimulation for termination and prevention of reentrant tachycardias

Subthreshold electrical stimulation (STS) was used to terminate and prevent reentrant supraventricular and ventricular (VT) tachycardia. Of 12 patients with SVT, 8 had atrioventricular nodal (AVN) reentry, and 4 had orthodromic tachycardias. Trains of STS applied close to the AVN area terminated the tachycardias in five of the eight patients with AVN re-entry and two of the patients with orthodromic tachycardia. In 13 patients with recurrent sustained hemodynamically stable VT (mean cycle length 370 +/- 40 ms), trains of STS were delivered at the site of early activity during the tachycardia. Number of train cycles ranged between 3 to 8 pulses and their cycle lengths ranged between 20 and 70 ms. In 7 of the 13 patients VTs were effectively terminated by STS application close to the site of early activity and in the remaining 6 patients it did not. In nine patients the effect of STS applied at the site of early activity on VT induction from the right ventricular apex was examined. In four of the nine patients STS prevented VT induction and in the remaining five patients it did not. These observations suggest that STS applied in proximity to the area critical for initiation and maintenance of reentry can terminate or prevent induction of the tachycardia.

How to evaluate class III antiarrhythmic drug efficacy clinically : the benefits and shortcomings of the invasive approach

Ventricular tachycardia and ventricular fibrillation are frequent complications of organic heart disease. There is sufficient evidence that serial electrophysiologic testing is able to predict long-term efficacy of antiarrhythmic agents in patients with malignant ventricular tachyarrhythmias. This approach has not only been useful for the evaluation of class I drugs, but recent studies have shown that this invasive method may also be useful for the management of patients undergoing treatment with class III antiarrhythmic agents such as amiodarone and sotalol. The results of several studies suggest that class III agents are more effective than class I drugs in patients presenting with ventricular tachycardia or ventricular fibrillation. Proarrhythmic complications in patients treated with class III antiarrhythmic drugs are mainly characterized by torsades de pointes. Their incidence does not exceed 5%. Further studies are necessary to elucidate the mechanisms underlying this type of proarrhythmia. By the use of currently available stimulation techniques, patients who might develop torsades de pointes while on therapy with a class III agent cannot be identified.